Evidence map›Paper›PMID 36789755›Full record

ArticleActa dermato-venereologica2023

Specific-class Skin Side-effects of Drugs Might Compromise Blinding in Randomized Controlled Trials.

Giao Do-Pham, Annabel Maruani, Sophie Leducq, Bruno Giraudeau, Olivier Chosidow

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta dermato-venereologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giao Do-PhamDepartment of Dermatology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Paris, France; Department of Internal Medicine, Intercommunal Creteil Hospital, Créteil, France.
Annabel MaruaniUniversities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France; Department of Dermatology, Centre Hospitalier Régional Universitaire (CHRU) Tours, Tours, France. annabel.maruani@univ-tours.fr.
Sophie LeducqUniversities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France; Department of Dermatology, Centre Hospitalier Régional Universitaire (CHRU) Tours, Tours, France.
Bruno Giraudeau *Universities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France; INSERM CIC 1415, CHRU Tours, Tours, France.
Olivier Chosidow *Department of Dermatology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Henri Mondor, Paris, France; Universities of Tours et Nantes, INSERM 1246-SPHERE, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug-Related Side Effects and Adverse ReactionsDouble-Blind MethodHumansIatrogenic DiseaseRandomized Controlled Trials as TopicSkin

Identifiers

PMID36789755
PMCPMC9944189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.